Citi Updates STJ Price Target to $38

by Patrick Henderson, Benzinga Staff Writer
March 15, 2011 8:26 AM | 8 seconds read |

Citi updated St Jude Medical Inc's STJ Price Target to $38. STJ is rated Sell/Medium Risk.

STJ sold at $48.38 at closing yesterday.

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Analyst ColorPrice TargetAnalyst RatingsCitiHealth CareHealth Care EquipmentSt Jude Medical Inc
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!